We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

192 hedge funds and large institutions have $6.65B invested in BeOne Medicines Ltd in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 32

140% more call options, than puts

Call options by funds: $50.8M | Put options by funds: $21.1M

117% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 30

56% more funds holding in top 10

Funds holding in top 10: 9 → 14 (+5)

33% more funds holding

Funds holding: 144 → 192 (+48)

0.23% more ownership

Funds ownership: 5.95% → 6.18% (+0.23%)

15% less capital invested

Capital invested by funds: $7.84B → $6.65B (-$1.19B)

Holders
192
Holders Change
+48
Holders Change %
+33.33%
% of All Funds
4.28%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.31%
New
82
Increased
65
Reduced
30
Closed
32
Calls
$50.8M
Puts
$21.1M
Net Calls
+$29.6M
Net Calls Change
+$49.2M

Top Buyers

1
BlackRock
BlackRock
New York
+$186M
2
Capital International Investors
Capital International Investors
California
+$136M
3
Northern Trust
Northern Trust
Illinois
+$74.8M
4
State Street
State Street
Massachusetts
+$68.8M
5
CGT
Capital Guardian Trust
California
+$44.9M

Top Sellers

1
HIM
Hillhouse Investment Management
Cayman Islands
-$589M
2
HSBC Holdings
HSBC Holdings
United Kingdom
-$348M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$315M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$44.4M
5
Renaissance Technologies
Renaissance Technologies
New York
-$24.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$1.68B – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$785M +$17M +128,072 +2%
HA
3
HHLR Advisors
Cayman Islands
$622M +$589M +4,437,953 New
Wellington Management Group
4
Wellington Management Group
Massachusetts
$389M -$14.6M -109,976 -4%
Temasek Holdings
5
Temasek Holdings
Singapore
$318M – – –
BlackRock
6
BlackRock
New York
$263M +$186M +1,401,773 +295%
Vanguard Group
7
Vanguard Group
Pennsylvania
$168M +$17.6M +133,060 +13%
Canada Pension Plan Investment Board
8
Canada Pension Plan Investment Board
Ontario, Canada
$157M +$746K +5,627 +0.5%
HIM
9
Hillhouse Investment Management
Cayman Islands
$145M -$589M -4,437,953 -81%
Capital International Investors
10
Capital International Investors
California
$144M +$136M +1,025,506 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$133M -$44.4M -335,086 -26%
Primecap Management
12
Primecap Management
California
$129M +$6.1M +46,000 +5%
BC
13
Boxer Capital
California
$126M +$35.8M +270,000 +43%
State Street
14
State Street
Massachusetts
$84.9M +$68.8M +518,922 +599%
AG
15
Artal Group
Luxembourg
$84.2M – – –
O
16
OppenheimerFunds
New York
$80.5M +$18.8M +141,660 +33%
Northern Trust
17
Northern Trust
Illinois
$79.4M +$74.8M +563,865 +22,043%
Janus Henderson Group
18
Janus Henderson Group
United Kingdom
$67.3M +$4.97M +37,506 +8%
AllianceBernstein
19
AllianceBernstein
Tennessee
$52.9M +$13M +98,116 +35%
Ameriprise
20
Ameriprise
Minnesota
$52.4M +$20.8M +156,536 +72%
Norges Bank
21
Norges Bank
Norway
$47.8M – – –
CGT
22
Capital Guardian Trust
California
$47.5M +$44.9M +338,761 New
Morgan Stanley
23
Morgan Stanley
New York
$44.6M -$4.52M -34,105 -10%
Russell Investments Group
24
Russell Investments Group
United Kingdom
$39.9M +$23.7M +178,984 +169%
O
25
OrbiMed
New York
$39.6M – – –
1
2 3 4 5

ONC Hedge Fund Activity: Q4 2018 in Review

192 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2018, worth a combined $6.65B — down 15% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new ONC positions and 32 closed out — a net gain of 50 holders — while 65 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $186M. The largest seller was Hillhouse Investment Management, cutting an estimated $589M.

  • 192 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2018, up from 144 in Q3 2018.
  • Funds reported $6.65B of BeOne Medicines Ltd stock for Q4 2018, down 15% quarter-over-quarter.
  • 82 funds opened new BeOne Medicines Ltd positions in Q4 2018 and 32 closed out, a net change of +50 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2018 was BlackRock, an estimated $186M added.
  • The largest BeOne Medicines Ltd seller in Q4 2018 was Hillhouse Investment Management, an estimated $589M sold.

Based on aggregated 13F filings for Q4 2018.